Shanghai Fosun Pharmaceutical Stock Last Dividend Paid
SFOSFDelisted Stock | USD 1.70 0.00 0.00% |
Shanghai Fosun Pharmaceutical fundamentals help investors to digest information that contributes to Shanghai Fosun's financial success or failures. It also enables traders to predict the movement of Shanghai Pink Sheet. The fundamental analysis module provides a way to measure Shanghai Fosun's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shanghai Fosun pink sheet.
Shanghai |
Shanghai Fosun Pharmaceutical Company Last Dividend Paid Analysis
Shanghai Fosun's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Current Shanghai Fosun Last Dividend Paid | 0.56 |
Most of Shanghai Fosun's fundamental indicators, such as Last Dividend Paid, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shanghai Fosun Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionBased on the recorded statements, Shanghai Fosun Pharmaceutical has a Last Dividend Paid of 0.56. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The last dividend paid for all United States stocks is notably lower than that of the firm.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Shanghai Fundamentals
Return On Equity | 0.0756 | |||
Return On Asset | 0.0204 | |||
Profit Margin | 0.08 % | |||
Operating Margin | 0.07 % | |||
Current Valuation | 15.52 B | |||
Shares Outstanding | 551.94 M | |||
Shares Owned By Insiders | 0.07 % | |||
Shares Owned By Institutions | 35.60 % | |||
Price To Earning | 13.80 X | |||
Price To Book | 1.45 X | |||
Price To Sales | 0.31 X | |||
Revenue | 39.01 B | |||
Gross Profit | 18.71 B | |||
EBITDA | 8.71 B | |||
Net Income | 4.74 B | |||
Cash And Equivalents | 14.64 B | |||
Cash Per Share | 5.49 X | |||
Total Debt | 9.05 B | |||
Debt To Equity | 0.64 % | |||
Current Ratio | 1.00 X | |||
Book Value Per Share | 16.30 X | |||
Cash Flow From Operations | 3.95 B | |||
Earnings Per Share | 0.21 X | |||
Number Of Employees | 36.28 K | |||
Beta | 0.76 | |||
Market Capitalization | 12.25 B | |||
Total Asset | 93.29 B | |||
Retained Earnings | 10.37 B | |||
Working Capital | (817 M) | |||
Current Asset | 10.27 B | |||
Current Liabilities | 11.09 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.03 % | |||
Net Asset | 93.29 B | |||
Last Dividend Paid | 0.56 |
About Shanghai Fosun Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shanghai Fosun Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanghai Fosun using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanghai Fosun Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Shanghai Pink Sheet
If you are still planning to invest in Shanghai Fosun Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shanghai Fosun's history and understand the potential risks before investing.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |